iScribe AI
AI medical scribe for clinicians
Nashville, Tennessee, United States
iScribe AI is an ambient AI documentation partner of Athenahealth. It was acquired in February 2022 for $17 billion by Bain Capital and Hellman & Friedman.
How We Help
Problem Statement
The company addresses the significant administrative and documentation burden faced by healthcare providers, which takes away time from patient care and contributes to physician burnout.
Core Technology
Generative AI, speech-to-text capabilities, ambient AI, integration with Electronic Health Record (EHR) systems.
Key Differentiators
Real-time medical documentation during patient encounters, seamless integration with existing EHR systems, automated creation of comprehensive and structured clinical notes, reduction of physician burnout, increased productivity, improved patient outcomes, and an embedded AI-powered ambient model within athenahealth's new Ambient Notes solution.
Clinical Focus
Transforming physician documentation and alleviating the burden associated with it across all specialties and provider types.
Target Customers
Healthcare providers, physicians across all specialties and provider types.
Company Info
- Business Model
- iScribe AI leverages generative AI and speech-to-text to automate and streamline medical documentation from patient-provider conversations, integrating directly with existing EHR systems. Its model focuses on reducing documentation burden, improving efficiency and revenue through accelerated documentation and optimized revenue cycle performance, offering customization, and providing a mobile-first experience.
- Founded
- 2015
- Total Funding
- 17,000,000,000
- Website
- iScribeHealth.com
Categories
Technologies
Clinical & IP
Clinical Validation
No published peer-reviewed clinical trials. Platform FDA status: device classification unclear. Validation: internal case studies show 6+ hours weekly documentation savings in orthopedic specialties; SOC 2 Type I certified for security.
MedStartr Index Score
?What do you think of iScribe AI?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.